Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Mesoblast Limited (MESO) vs YieldMax Universe Fund of Option Income ETFs (YMAX) Price & Performance

Mesoblast LimitedTrade
YieldMax Universe Fund of Option Income ETFsTrade

Price performance (Past 24H)

Key statistics

Mesoblast Limited vs YieldMax Universe Fund of Option Income ETFs — how do they compare? Mesoblast Limited trades at $16.98 (market cap $2.21B), while YieldMax Universe Fund of Option Income ETFs trades at $7.65. The key difference: Mesoblast Limited is trading nearer its 52-week high, YieldMax Universe Fund of Option Income ETFs nearer its low. Which is the better fit depends on your goals.

MESOYMAX
Market Cap
$2.21B
Sector
TechnologyIncome / Options Overlay
52-Week High
$20.96$13.26
52-Week Low
$12.88$7.27
Enterprise Value
$2.21B

Returns comparison

Trailing returns across standard periods

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO

About YieldMax Universe Fund of Option Income ETFs

YMAX is an actively managed 'fund of funds' that provides equal-weighted exposure to the full suite of YieldMax option income ETFs. It is designed to generate high current income by aggregating the premiums from various single-stock and thematic covered call strategies, offering a diversified approach to high-yield option investing.

Read more on YMAX